-
1
-
-
84858788212
-
Approach to and treatment of differentiated thyroid carcinoma
-
PID: 22443981, COI: 1:CAS:528:DC%2BC38XksFaqtr0%3D
-
Pacini F, Castagna MG (2012) Approach to and treatment of differentiated thyroid carcinoma. Med Clin N Am 96(2):369–383. doi:10.1016/j.mcna.2012.01.002
-
(2012)
Med Clin N Am
, vol.96
, Issue.2
, pp. 369-383
-
-
Pacini, F.1
Castagna, M.G.2
-
2
-
-
84878014227
-
Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology
-
PID: 23076684
-
Kitano M, Sugitani I, Toda K, Ikenaga M, Motoi N, Yamamoto N, Hotomi M, Fujimoto Y, Kawabata K (2013) Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology. Surg Today 43(6):632–637. doi:10.1007/s00595-012-0362-y
-
(2013)
Surg Today
, vol.43
, Issue.6
, pp. 632-637
-
-
Kitano, M.1
Sugitani, I.2
Toda, K.3
Ikenaga, M.4
Motoi, N.5
Yamamoto, N.6
Hotomi, M.7
Fujimoto, Y.8
Kawabata, K.9
-
5
-
-
84864848268
-
BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion
-
PID: 22105775, COI: 1:CAS:528:DC%2BC38Xms12gtLg%3D
-
Chakraborty A, Narkar A, Mukhopadhyaya R, Kane S, D’Cruz A, Rajan MG (2012) BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion. Endocr pathol 23(2):83–93. doi:10.1007/s12022-011-9184-5
-
(2012)
Endocr pathol
, vol.23
, Issue.2
, pp. 83-93
-
-
Chakraborty, A.1
Narkar, A.2
Mukhopadhyaya, R.3
Kane, S.4
D’Cruz, A.5
Rajan, M.G.6
-
6
-
-
73249132998
-
Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status
-
PID: 19850689, COI: 1:CAS:528:DC%2BD1MXhsFyltb%2FI
-
Cradic KW, Milosevic D, Rosenberg AM, Erickson LA, McIver B, Grebe SK (2009) Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status. J Clin Endocrinol Metab 94(12):5001–5009. doi:10.1210/jc.2009-1349
-
(2009)
J Clin Endocrinol Metab
, vol.94
, Issue.12
, pp. 5001-5009
-
-
Cradic, K.W.1
Milosevic, D.2
Rosenberg, A.M.3
Erickson, L.A.4
McIver, B.5
Grebe, S.K.6
-
7
-
-
77956571967
-
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1,060 cases
-
PID: 20631031, COI: 1:CAS:528:DC%2BC3cXht1Wms7%2FL
-
Basolo F, Torregrossa L, Giannini R, Miccoli M, Lupi C, Sensi E, Berti P, Elisei R, Vitti P, Baggiani A, Miccoli P (2010) Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1,060 cases. J Clin Endocr Metab 95(9):4197–4205. doi:10.1210/Jc.2010-0337
-
(2010)
J Clin Endocr Metab
, vol.95
, Issue.9
, pp. 4197-4205
-
-
Basolo, F.1
Torregrossa, L.2
Giannini, R.3
Miccoli, M.4
Lupi, C.5
Sensi, E.6
Berti, P.7
Elisei, R.8
Vitti, P.9
Baggiani, A.10
Miccoli, P.11
-
8
-
-
84857457602
-
BRAF(V600E) Mutation is associated with tumor aggressiveness in papillary thyroid cancer
-
PID: 22190222
-
Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo DH, Youn YK (2012) BRAF(V600E) Mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg 36(2):310–317. doi:10.1007/s00268-011-1383-1
-
(2012)
World J Surg
, vol.36
, Issue.2
, pp. 310-317
-
-
Kim, S.J.1
Lee, K.E.2
Myong, J.P.3
Park, J.H.4
Jeon, Y.K.5
Min, H.S.6
Park, S.Y.7
Jung, K.C.8
Koo, D.H.9
Youn, Y.K.10
-
9
-
-
84861922322
-
BRAF(V600E) status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China
-
Zheng XQ, Xia TT, Lin L, Gao SY, Lee YG, Yu Y, Wei SF, Gao M (2012) BRAF(V600E) status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China. World J Surg Oncol 10. doi:10.1186/1477-7819-10-104
-
(2012)
World J Surg Oncol
, pp. 10
-
-
Zheng, X.Q.1
Xia, T.T.2
Lin, L.3
Gao, S.Y.4
Lee, Y.G.5
Yu, Y.6
Wei, S.F.7
Gao, M.8
-
10
-
-
84859099960
-
Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer?
-
PID: 21803329, COI: 1:CAS:528:DC%2BC38XksFehu7Y%3D
-
Nam JK, Jung CK, Song BJ, Lim DJ, Chae BJ, Lee NS, Park WC, Kim JS, Jung SS, Bae JS (2012) Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Am J Surg 203(4):436–441. doi:10.1016/j.amjsurg.2011.02.013
-
(2012)
Am J Surg
, vol.203
, Issue.4
, pp. 436-441
-
-
Nam, J.K.1
Jung, C.K.2
Song, B.J.3
Lim, D.J.4
Chae, B.J.5
Lee, N.S.6
Park, W.C.7
Kim, J.S.8
Jung, S.S.9
Bae, J.S.10
-
11
-
-
53749086690
-
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study
-
PID: 18682506, COI: 1:CAS:528:DC%2BD1cXht1Gmur3O
-
Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F (2008) BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocr Metab 93(10):3943–3949. doi:10.1210/Jc.2008-0607
-
(2008)
J Clin Endocr Metab
, vol.93
, Issue.10
, pp. 3943-3949
-
-
Elisei, R.1
Ugolini, C.2
Viola, D.3
Lupi, C.4
Biagini, A.5
Giannini, R.6
Romei, C.7
Miccoli, P.8
Pinchera, A.9
Basolo, F.10
-
12
-
-
84863574283
-
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome
-
PID: 22508706, COI: 1:CAS:528:DC%2BC38XhtFGgs7vM
-
Guerra A, Fugazzola L, Marotta V, Cirillo M, Rossi S, Cirello V, Forno I, Moccia T, Budillon A, Vitale M (2012) A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J Clin Endocrinol Metab 97(7):2333–2340. doi:10.1210/jc.2011-3106
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.7
, pp. 2333-2340
-
-
Guerra, A.1
Fugazzola, L.2
Marotta, V.3
Cirillo, M.4
Rossi, S.5
Cirello, V.6
Forno, I.7
Moccia, T.8
Budillon, A.9
Vitale, M.10
-
13
-
-
84876336444
-
Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma
-
PID: 23528368, COI: 1:CAS:528:DC%2BC3sXksFOrsbk%3D
-
Pyo JS, Kang G, Kim DH, Chae SW, Park C, Kim K, Do SI, Lee HJ, Kim JH, Sohn JH (2013) Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma. Pathol Res Pract 209(4):228–232. doi:10.1016/j.prp.2013.02.004
-
(2013)
Pathol Res Pract
, vol.209
, Issue.4
, pp. 228-232
-
-
Pyo, J.S.1
Kang, G.2
Kim, D.H.3
Chae, S.W.4
Park, C.5
Kim, K.6
Do, S.I.7
Lee, H.J.8
Kim, J.H.9
Sohn, J.H.10
-
14
-
-
33750062281
-
Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci
-
PID: 16983703, COI: 1:CAS:528:DC%2BD28Xht1Cms7bK
-
Park SY, Park YJ, Lee YJ, Lee HS, Choi SH, Choe G, Jang HC, Park SH, do Park J, Cho BY (2006) Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci. Cancer 107(8):1831–1838. doi:10.1002/cncr.22218
-
(2006)
Cancer
, vol.107
, Issue.8
, pp. 1831-1838
-
-
Park, S.Y.1
Park, Y.J.2
Lee, Y.J.3
Lee, H.S.4
Choi, S.H.5
Choe, G.6
Jang, H.C.7
Park, S.H.8
do Park, J.9
Cho, B.Y.10
-
15
-
-
82955233568
-
Both BRAF V600E mutation and older age (≥65 years) are associated with recurrent papillary thyroid cancer
-
PID: 21594703
-
Howell GM, Carty SE, Armstrong MJ, LeBeau SO, Hodak SP, Coyne C, Stang MT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L (2011) Both BRAF V600E mutation and older age (≥65 years) are associated with recurrent papillary thyroid cancer. Ann Surg Oncol 18(13):3566–3571. doi:10.1245/s10434-011-1781-5
-
(2011)
Ann Surg Oncol
, vol.18
, Issue.13
, pp. 3566-3571
-
-
Howell, G.M.1
Carty, S.E.2
Armstrong, M.J.3
LeBeau, S.O.4
Hodak, S.P.5
Coyne, C.6
Stang, M.T.7
McCoy, K.L.8
Nikiforova, M.N.9
Nikiforov, Y.E.10
Yip, L.11
-
16
-
-
84859994009
-
BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients
-
PID: 22515292, COI: 1:CAS:528:DC%2BC38XpsFOnu7w%3D
-
Pelttari H, Schalin-Jantti C, Arola J, Loyttyniemi E, Knuutila S, Valimaki MJ (2012) BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients. Apmis 120(5):380–386. doi:10.1111/j.1600-0463.2011.02844.x
-
(2012)
Apmis
, vol.120
, Issue.5
, pp. 380-386
-
-
Pelttari, H.1
Schalin-Jantti, C.2
Arola, J.3
Loyttyniemi, E.4
Knuutila, S.5
Valimaki, M.J.6
-
17
-
-
84863237562
-
BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles
-
PID: 22358007
-
Moon WJ, Choi N, Choi JW, Kim SK, Hwang TS (2012) BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. AJR Am J Roentgenol 198(3):668–674. doi:10.2214/AJR.11.7185
-
(2012)
AJR Am J Roentgenol
, vol.198
, Issue.3
, pp. 668-674
-
-
Moon, W.J.1
Choi, N.2
Choi, J.W.3
Kim, S.K.4
Hwang, T.S.5
-
18
-
-
62549101651
-
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients
-
PID: 18840924, COI: 1:CAS:528:DC%2BD1MXlvVWgtrg%3D
-
Ito Y, Yoshida H, Maruo R, Morita S, Takano T, Hirokawa M, Yabuta T, Fukushima M, Inoue H, Tomoda C, Kihara M, Uruno T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2009) BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J 56(1):89–97
-
(2009)
Endocr J
, vol.56
, Issue.1
, pp. 89-97
-
-
Ito, Y.1
Yoshida, H.2
Maruo, R.3
Morita, S.4
Takano, T.5
Hirokawa, M.6
Yabuta, T.7
Fukushima, M.8
Inoue, H.9
Tomoda, C.10
Kihara, M.11
Uruno, T.12
Higashiyama, T.13
Takamura, Y.14
Miya, A.15
Kobayashi, K.16
Matsuzuka, F.17
Miyauchi, A.18
-
19
-
-
84855953821
-
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy
-
PID: 21903858, COI: 1:CAS:528:DC%2BC38XitFCgs78%3D
-
Bommarito A, Richiusa P, Carissimi E, Pizzolanti G, Rodolico V, Zito G, Criscimanna A, Di Blasi F, Pitrone M, Zerilli M, Amato MC, Spinelli G, Carina V, Modica G, Latteri MA, Galluzzo A, Giordano C (2011) BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy. Endocr Relat Cancer 18(6):669–685. doi:10.1530/ERC-11-0076
-
(2011)
Endocr Relat Cancer
, vol.18
, Issue.6
, pp. 669-685
-
-
Bommarito, A.1
Richiusa, P.2
Carissimi, E.3
Pizzolanti, G.4
Rodolico, V.5
Zito, G.6
Criscimanna, A.7
Di Blasi, F.8
Pitrone, M.9
Zerilli, M.10
Amato, M.C.11
Spinelli, G.12
Carina, V.13
Modica, G.14
Latteri, M.A.15
Galluzzo, A.16
Giordano, C.17
-
20
-
-
84855273062
-
BRAF(V600E) mutation analysis from May-Grunwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma
-
PID: 21948220, COI: 1:CAS:528:DC%2BC3MXhsFylu77N
-
Patel A, Klubo-Gwiezdzinska J, Hoperia V, Larin A, Jensen K, Bauer A, Vasko V (2011) BRAF(V600E) mutation analysis from May-Grunwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma. Endocr Pathol 22(4):195–199. doi:10.1007/s12022-011-9180-9
-
(2011)
Endocr Pathol
, vol.22
, Issue.4
, pp. 195-199
-
-
Patel, A.1
Klubo-Gwiezdzinska, J.2
Hoperia, V.3
Larin, A.4
Jensen, K.5
Bauer, A.6
Vasko, V.7
-
21
-
-
78649952872
-
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer
-
PID: 21134544
-
O’Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS (2010) BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 148(6):1139–1145. doi:10.1016/j.surg.2010.09.005
-
(2010)
Surgery
, vol.148
, Issue.6
, pp. 1139-1145
-
-
O’Neill, C.J.1
Bullock, M.2
Chou, A.3
Sidhu, S.B.4
Delbridge, L.W.5
Robinson, B.G.6
Gill, A.J.7
Learoyd, D.L.8
Clifton-Bligh, R.9
Sywak, M.S.10
-
22
-
-
84856706936
-
BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma
-
PID: 21862261
-
Ahn D, Park JS, Sohn JH, Kim JH, Park SK, Seo AN, Park JY (2012) BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma. Auris Nasus Larynx 39(2):198–203. doi:10.1016/j.anl.2011.07.011
-
(2012)
Auris Nasus Larynx
, vol.39
, Issue.2
, pp. 198-203
-
-
Ahn, D.1
Park, J.S.2
Sohn, J.H.3
Kim, J.H.4
Park, S.K.5
Seo, A.N.6
Park, J.Y.7
-
23
-
-
84875222136
-
BRAF(V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR
-
PID: 23179992
-
Jeong D, Jeong Y, Park JH, Han SW, Kim SY, Kim YJ, Kim SJ, Hwangbo Y, Park S, Cho HD, Oh MH, Yang SH, Kim CJ (2013) BRAF(V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR. Ann Surg Oncol 20(3):759–766. doi:10.1245/s10434-012-2494-0
-
(2013)
Ann Surg Oncol
, vol.20
, Issue.3
, pp. 759-766
-
-
Jeong, D.1
Jeong, Y.2
Park, J.H.3
Han, S.W.4
Kim, S.Y.5
Kim, Y.J.6
Kim, S.J.7
Hwangbo, Y.8
Park, S.9
Cho, H.D.10
Oh, M.H.11
Yang, S.H.12
Kim, C.J.13
-
24
-
-
84875382648
-
BRAF(V600E) mutation in fine-needle aspiration aspirates: association with poorer prognostic factors in larger papillary thyroid carcinomas
-
Lee JI, Jang HW, Kim SW, Kim JW, Oh YL, Chung JH (2013) BRAF(V600E) mutation in fine-needle aspiration aspirates: association with poorer prognostic factors in larger papillary thyroid carcinomas. Head Neck J Sci Spec 35(4):548–553. doi:10.1002/Hed.22997
-
(2013)
Head Neck J Sci Spec
, vol.35
, Issue.4
, pp. 548-553
-
-
Lee, J.I.1
Jang, H.W.2
Kim, S.W.3
Kim, J.W.4
Oh, Y.L.5
Chung, J.H.6
-
25
-
-
77955176654
-
BRAF(V600E) mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer
-
COI: 1:CAS:528:DC%2BC3cXpsFeks74%3D
-
Zerilli M, Zito G, Martorana A, Pitrone M, Cabibi D, Cappello F, Giordano C, Rodolico V (2010) BRAF(V600E) mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer. Mod Pathol Off J US Can Acad Pathol Inc 23(8):1052–1060. doi:10.1038/modpathol.2010.86
-
(2010)
Mod Pathol Off J US Can Acad Pathol Inc
, vol.23
, Issue.8
, pp. 1052-1060
-
-
Zerilli, M.1
Zito, G.2
Martorana, A.3
Pitrone, M.4
Cabibi, D.5
Cappello, F.6
Giordano, C.7
Rodolico, V.8
-
26
-
-
84867352088
-
BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
-
PID: 22426956, COI: 1:CAS:528:DC%2BC38XktVKisbk%3D
-
Kurtulmus N, Duren M, Ince U, Cengiz Yakicier M, Peker O, Aydin O, Altiok E, Giray S, Azizlerli H (2012) BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine 42(2):404–410. doi:10.1007/s12020-012-9651-x
-
(2012)
Endocrine
, vol.42
, Issue.2
, pp. 404-410
-
-
Kurtulmus, N.1
Duren, M.2
Ince, U.3
Cengiz Yakicier, M.4
Peker, O.5
Aydin, O.6
Altiok, E.7
Giray, S.8
Azizlerli, H.9
-
27
-
-
84871923882
-
BRAF(V600E) mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation
-
PID: 22918165, COI: 1:CAS:528:DC%2BC3sXjs12ksQ%3D%3D
-
Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML (2013) BRAF(V600E) mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol 26(1):62–70. doi:10.1038/modpathol.2012.152
-
(2013)
Mod Pathol
, vol.26
, Issue.1
, pp. 62-70
-
-
Virk, R.K.1
Van Dyke, A.L.2
Finkelstein, A.3
Prasad, A.4
Gibson, J.5
Hui, P.6
Theoharis, C.G.7
Carling, T.8
Roman, S.A.9
Sosa, J.A.10
Udelsman, R.11
Prasad, M.L.12
-
28
-
-
84863570549
-
Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4,585 consecutive cases in a BRAF V600E mutation-prevalent area
-
PID: 22500044, COI: 1:CAS:528:DC%2BC38XhtFGgs7rK
-
Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH (2012) Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4,585 consecutive cases in a BRAF V600E mutation-prevalent area. J Clin Endocr Metab 97(7):2299–2306. doi:10.1210/Jc.2011-3135
-
(2012)
J Clin Endocr Metab
, vol.97
, Issue.7
, pp. 2299-2306
-
-
Lee, S.T.1
Kim, S.W.2
Ki, C.S.3
Jang, J.H.4
Shin, J.H.5
Oh, Y.L.6
Kim, J.W.7
Chung, J.H.8
-
29
-
-
33745074644
-
Correlation between B-RAF(V600E) mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature
-
PID: 16728573, COI: 1:STN:280:DC%2BD283pslGmtQ%3D%3D
-
Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R (2006) Correlation between B-RAF(V600E) mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer 13(2):455–464. doi:10.1677/Erc.1.01086
-
(2006)
Endocr Relat Cancer
, vol.13
, Issue.2
, pp. 455-464
-
-
Fugazzola, L.1
Puxeddu, E.2
Avenia, N.3
Romei, C.4
Cirello, V.5
Cavaliere, A.6
Faviana, P.7
Mannavola, D.8
Moretti, S.9
Rossi, S.10
Sculli, M.11
Bottici, V.12
Beck-Peccoz, P.13
Pacini, F.14
Pinchera, A.15
Santeusanio, F.16
Elisei, R.17
-
30
-
-
84863231928
-
Detection of BRAF(V600E) mutations in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR: a comparison with direct sequencing
-
PID: 23109980
-
Jeong D, Jeong Y, Lee S, Lee H, Lee W, Kim H, Park D, Park S, Mu W, Cho HD, Oh MH, Lee SS, Yang SH, Kim CJ (2012) Detection of BRAF(V600E) mutations in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR: a comparison with direct sequencing. Korean J Pathol 46(1):61–67. doi:10.4132/KoreanJPathol.46.1.61
-
(2012)
Korean J Pathol
, vol.46
, Issue.1
, pp. 61-67
-
-
Jeong, D.1
Jeong, Y.2
Lee, S.3
Lee, H.4
Lee, W.5
Kim, H.6
Park, D.7
Park, S.8
Mu, W.9
Cho, H.D.10
Oh, M.H.11
Lee, S.S.12
Yang, S.H.13
Kim, C.J.14
-
31
-
-
33644586429
-
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA)
-
PID: 16452550, COI: 1:CAS:528:DC%2BD28XitlGltL4%3D
-
Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G, Vitale M (2006) Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 154(2):341–348. doi:10.1530/eje.1.02072
-
(2006)
Eur J Endocrinol
, vol.154
, Issue.2
, pp. 341-348
-
-
Sapio, M.R.1
Posca, D.2
Troncone, G.3
Pettinato, G.4
Palombini, L.5
Rossi, G.6
Fenzi, G.7
Vitale, M.8
-
32
-
-
84862743813
-
Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer
-
PID: 22535643, COI: 1:CAS:528:DC%2BC38XhtFSqu77P
-
Lee JU, Huang S, Lee MH, Lee SE, Ryu MJ, Kim SJ, Kim YK, Kim SY, Joung KH, Kim JM, Shong M, Jo YS (2012) Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer. Eur J Endocrinol 167(1):93–101. doi:10.1530/Eje-12-0010
-
(2012)
Eur J Endocrinol
, vol.167
, Issue.1
, pp. 93-101
-
-
Lee, J.U.1
Huang, S.2
Lee, M.H.3
Lee, S.E.4
Ryu, M.J.5
Kim, S.J.6
Kim, Y.K.7
Kim, S.Y.8
Joung, K.H.9
Kim, J.M.10
Shong, M.11
Jo, Y.S.12
-
33
-
-
84862109270
-
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma
-
PID: 22592144
-
Koperek O, Kornauth C, Capper D, Berghoff AS, Asari R, Niederle B, von Deimling A, Birner P, Preusser M (2012) Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma. Am J Surg Pathol 36(6):844–850. doi:10.1097/PAS.0b013e318246b527
-
(2012)
Am J Surg Pathol
, vol.36
, Issue.6
, pp. 844-850
-
-
Koperek, O.1
Kornauth, C.2
Capper, D.3
Berghoff, A.S.4
Asari, R.5
Niederle, B.6
von Deimling, A.7
Birner, P.8
Preusser, M.9
-
34
-
-
84867259293
-
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval
-
COI: 1:CAS:528:DC%2BC38XhsVKls7nJ
-
Ulisse S, Baldini E, Sorrenti S, Barollo S, Prinzi N, Catania A, Nesca A, Gnessi L, Pelizzo MR, Mian C, De Vito C, Calvanese A, Palermo S, Persechino S, De Antoni E, D’Armiento M (2012) In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval. Clin Endocrinol 77(5):780–786. doi:10.1111/j.1365-2265.2012.04465.x
-
(2012)
Clin Endocrinol
, vol.77
, Issue.5
, pp. 780-786
-
-
Ulisse, S.1
Baldini, E.2
Sorrenti, S.3
Barollo, S.4
Prinzi, N.5
Catania, A.6
Nesca, A.7
Gnessi, L.8
Pelizzo, M.R.9
Mian, C.10
De Vito, C.11
Calvanese, A.12
Palermo, S.13
Persechino, S.14
De Antoni, E.15
D’Armiento, M.16
-
35
-
-
84869495830
-
Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?
-
PID: 23062653
-
Lee KC, Li C, Schneider EB, Wang Y, Somervell H, Krafft M, Umbricht CB, Zeiger MA (2012) Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer? Surgery 152(6):977–983. doi:10.1016/j.surg.2012.08.019
-
(2012)
Surgery
, vol.152
, Issue.6
, pp. 977-983
-
-
Lee, K.C.1
Li, C.2
Schneider, E.B.3
Wang, Y.4
Somervell, H.5
Krafft, M.6
Umbricht, C.B.7
Zeiger, M.A.8
-
36
-
-
33845588905
-
Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma
-
PID: 17199737, COI: 1:CAS:528:DC%2BD2sXhsVSmsbk%3D
-
Zuo H, Nakamura Y, Yasuoka H, Zhang P, Nakamura M, Mori I, Miyauchi A, Kakudo K (2007) Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma. Pathol Int 57(1):12–20. doi:10.1111/j.1440-1827.2007.02050.x
-
(2007)
Pathol Int
, vol.57
, Issue.1
, pp. 12-20
-
-
Zuo, H.1
Nakamura, Y.2
Yasuoka, H.3
Zhang, P.4
Nakamura, M.5
Mori, I.6
Miyauchi, A.7
Kakudo, K.8
-
37
-
-
68149162638
-
Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of mirnas in papillary thyroid carcinoma
-
PID: 19370505, COI: 1:CAS:528:DC%2BD1MXovV2rt7w%3D
-
Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW (2009) Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of mirnas in papillary thyroid carcinoma. Horm Metab Res 41(6):482–487. doi:10.1055/s-0029-1215558
-
(2009)
Horm Metab Res
, vol.41
, Issue.6
, pp. 482-487
-
-
Sheu, S.Y.1
Grabellus, F.2
Schwertheim, S.3
Handke, S.4
Worm, K.5
Schmid, K.W.6
-
38
-
-
79958064993
-
Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia
-
PID: 21498916, COI: 1:CAS:528:DC%2BC3MXhtFKjtL7M
-
Stanojevic B, Dzodic R, Saenko V, Milovanovic Z, Pupic G, Zivkovic O, Markovic I, Djurisic I, Buta M, Dimitrijevic B, Rogounovitch T, Mitsutake N, Mine M, Shibata Y, Nakashima M, Yamashita S (2011) Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia. Endocr J 58(5):381–393
-
(2011)
Endocr J
, vol.58
, Issue.5
, pp. 381-393
-
-
Stanojevic, B.1
Dzodic, R.2
Saenko, V.3
Milovanovic, Z.4
Pupic, G.5
Zivkovic, O.6
Markovic, I.7
Djurisic, I.8
Buta, M.9
Dimitrijevic, B.10
Rogounovitch, T.11
Mitsutake, N.12
Mine, M.13
Shibata, Y.14
Nakashima, M.15
Yamashita, S.16
-
39
-
-
84862779814
-
Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer
-
Park HS, Jung CK, Lee SH, Chae BJ, Lim DJ, Park WC, Song BJ, Kim JS, Jung SS, Bae JS (2012) Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer. Cancer Sci 103(2):305. doi:10.1111/j.1349-7006.2011.02161.x
-
(2012)
Cancer Sci
, vol.103
, Issue.2
, pp. 305
-
-
Park, H.S.1
Jung, C.K.2
Lee, S.H.3
Chae, B.J.4
Lim, D.J.5
Park, W.C.6
Song, B.J.7
Kim, J.S.8
Jung, S.S.9
Bae, J.S.10
-
40
-
-
84861480417
-
Papillary thyroid carcinomas with and without BRAF? V600E mutations are morphologically distinct
-
PID: 22335197
-
Finkelstein A, Levy GH, Hui P, Prasad A, Virk R, Chhieng DC, Carling T, Roman SA, Sosa JA, Udelsman R, Theoharis CG, Prasad ML (2012) Papillary thyroid carcinomas with and without BRAF? V600E mutations are morphologically distinct. Histopathology 60(7):1052–1059. doi:10.1111/j.1365-2559.2011.04149.x
-
(2012)
Histopathology
, vol.60
, Issue.7
, pp. 1052-1059
-
-
Finkelstein, A.1
Levy, G.H.2
Hui, P.3
Prasad, A.4
Virk, R.5
Chhieng, D.C.6
Carling, T.7
Roman, S.A.8
Sosa, J.A.9
Udelsman, R.10
Theoharis, C.G.11
Prasad, M.L.12
-
41
-
-
77951950838
-
Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction
-
PID: 20410389
-
Hwang J, Shin JH, Han BK, Ko EY, Kang SS, Kim JW, Chung JH (2010) Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction. AJR Am J Roentgenol 194(5):W425–W430. doi:10.2214/AJR.09.3512
-
(2010)
AJR Am J Roentgenol
, vol.194
, Issue.5
, pp. W425-W430
-
-
Hwang, J.1
Shin, J.H.2
Han, B.K.3
Ko, E.Y.4
Kang, S.S.5
Kim, J.W.6
Chung, J.H.7
-
42
-
-
84856684811
-
Poorer prognosis and higher prevalence of BRAF(V600E) mutation in synchronous bilateral papillary thyroid carcinoma
-
PID: 22033631
-
Wang W, Zhao W, Wang H, Teng X, Chen X, Li Z, Yu X, Fahey TJ 3rd, Teng L (2012) Poorer prognosis and higher prevalence of BRAF(V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol 19(1):31–36. doi:10.1245/s10434-011-2096-2
-
(2012)
Ann Surg Oncol
, vol.19
, Issue.1
, pp. 31-36
-
-
Wang, W.1
Zhao, W.2
Wang, H.3
Teng, X.4
Chen, X.5
Li, Z.6
Yu, X.7
Fahey, T.J.8
Teng, L.9
-
43
-
-
84874300517
-
Progression of solitary and multifocal papillary thyroid carcinoma—a retrospective study of 368 patients
-
PID: 23253715
-
Zheng XQ, Wang C, Xu M, Yu Y, Yun XW, Jia YS, Wei SF, Ren XB, Gao M (2012) Progression of solitary and multifocal papillary thyroid carcinoma—a retrospective study of 368 patients. Chin Med J 125(24):4434–4439
-
(2012)
Chin Med J
, vol.125
, Issue.24
, pp. 4434-4439
-
-
Zheng, X.Q.1
Wang, C.2
Xu, M.3
Yu, Y.4
Yun, X.W.5
Jia, Y.S.6
Wei, S.F.7
Ren, X.B.8
Gao, M.9
-
44
-
-
79952309163
-
Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status
-
PID: 21239517, COI: 1:CAS:528:DC%2BC3MXjvFahsbw%3D
-
Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS (2011) Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab 96(3):658–664. doi:10.1210/jc.2010-1082
-
(2011)
J Clin Endocrinol Metab
, vol.96
, Issue.3
, pp. 658-664
-
-
Kim, S.K.1
Hwang, T.S.2
Yoo, Y.B.3
Han, H.S.4
Kim, D.L.5
Song, K.H.6
Lim, S.D.7
Kim, W.S.8
Paik, N.S.9
-
45
-
-
33747369828
-
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma
-
COI: 1:CAS:528:DC%2BD28XhtVOqtLjP
-
Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK (2006) The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol 65(3):364–368. doi:10.1111/j.1365-2265.2006.02605.x
-
(2006)
Clin Endocrinol
, vol.65
, Issue.3
, pp. 364-368
-
-
Kim, T.Y.1
Kim, W.B.2
Rhee, Y.S.3
Song, J.Y.4
Kim, J.M.5
Gong, G.6
Lee, S.7
Kim, S.Y.8
Kim, S.C.9
Hong, S.J.10
Shong, Y.K.11
-
46
-
-
27744512441
-
The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
-
COI: 1:CAS:528:DC%2BD2MXhtlamsLbM
-
Kim TY, Kim WB, Song JY, Rhee YS, Gong G, Cho YM, Kim SY, Kim SC, Hong SJ, Shong YK (2005) The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol 63(5):588–593. doi:10.1111/j.1365-2265.2005.02389.x
-
(2005)
Clin Endocrinol
, vol.63
, Issue.5
, pp. 588-593
-
-
Kim, T.Y.1
Kim, W.B.2
Song, J.Y.3
Rhee, Y.S.4
Gong, G.5
Cho, Y.M.6
Kim, S.Y.7
Kim, S.C.8
Hong, S.J.9
Shong, Y.K.10
-
47
-
-
77956276911
-
Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma
-
PID: 20543822
-
Jung CK, Kang YG, Bae JS, Lim DJ, Choi YJ, Lee KY (2010) Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma. Mod Pathol 23(9):1201–1208. doi:10.1038/modpathol.2010.116
-
(2010)
Mod Pathol
, vol.23
, Issue.9
, pp. 1201-1208
-
-
Jung, C.K.1
Kang, Y.G.2
Bae, J.S.3
Lim, D.J.4
Choi, Y.J.5
Lee, K.Y.6
-
48
-
-
84887995180
-
Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma
-
PID: 23931769
-
Zagzag J, Pollack A, Dultz L, Dhar S, Ogilvie JB, Heller KS, Deng FM, Patel KN (2013) Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma. Surgery. doi:10.1016/j.surg.2013.06.020
-
(2013)
Surgery
-
-
Zagzag, J.1
Pollack, A.2
Dultz, L.3
Dhar, S.4
Ogilvie, J.B.5
Heller, K.S.6
Deng, F.M.7
Patel, K.N.8
-
49
-
-
79952985927
-
Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant
-
PID: 21167555, COI: 1:CAS:528:DC%2BC3MXjs1yqu74%3D
-
Smith RA, Salajegheh A, Weinstein S, Nassiri M, Lam AKY (2011) Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant. Hum Pathol 42(4):500–506. doi:10.1016/j.humpath.2009.09.023
-
(2011)
Hum Pathol
, vol.42
, Issue.4
, pp. 500-506
-
-
Smith, R.A.1
Salajegheh, A.2
Weinstein, S.3
Nassiri, M.4
Lam, A.K.Y.5
-
50
-
-
84894647237
-
BRAF mutation analysis in papillary thyroid carcinoma: is it useful for all patients?
-
PID: 24045966
-
Ito Y, Yoshida H, Kihara M, Kobayashi K, Miya A, Miyauchi A (2013) BRAF mutation analysis in papillary thyroid carcinoma: is it useful for all patients? World J Surg. doi:10.1007/s00268-013-2223-2
-
(2013)
World J Surg
-
-
Ito, Y.1
Yoshida, H.2
Kihara, M.3
Kobayashi, K.4
Miya, A.5
Miyauchi, A.6
-
51
-
-
70350423010
-
The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology
-
PID: 19644722
-
Moon HJ, Kwak JY, Kim EK, Choi JR, Hong SW, Kim MJ, Son EJ (2009) The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology. Ann Surg Oncol 16(11):3125–3131. doi:10.1245/s10434-009-0644-9
-
(2009)
Ann Surg Oncol
, vol.16
, Issue.11
, pp. 3125-3131
-
-
Moon, H.J.1
Kwak, J.Y.2
Kim, E.K.3
Choi, J.R.4
Hong, S.W.5
Kim, M.J.6
Son, E.J.7
-
52
-
-
84880342513
-
Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
-
PID: 23883275, COI: 1:CAS:528:DC%2BC3sXhtl2iu73E
-
Kang SY, Ahn S, Lee SM, Jeong JY, Sung JY, Oh YL, Kim KM (2013) Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas. Diagn Pathol 8(1):121. doi:10.1186/1746-1596-8-121
-
(2013)
Diagn Pathol
, vol.8
, Issue.1
, pp. 121
-
-
Kang, S.Y.1
Ahn, S.2
Lee, S.M.3
Jeong, J.Y.4
Sung, J.Y.5
Oh, Y.L.6
Kim, K.M.7
-
53
-
-
35348984010
-
Clinical significance of BRAF(V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas
-
PID: 17972530, COI: 1:CAS:528:DC%2BD2sXhtlWjs7rM
-
Nakayama H, Yoshida A, Nakamura Y, Hayashi H, Miyagi Y, Wada N, Rino Y, Masuda M, Imada T (2007) Clinical significance of BRAF(V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas. Anticancer Res 27(5B):3645–3649
-
(2007)
Anticancer Res
, vol.27
, Issue.5B
, pp. 3645-3649
-
-
Nakayama, H.1
Yoshida, A.2
Nakamura, Y.3
Hayashi, H.4
Miyagi, Y.5
Wada, N.6
Rino, Y.7
Masuda, M.8
Imada, T.9
-
54
-
-
84859826774
-
Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule
-
PID: 21751431, COI: 1:CAS:528:DC%2BC38XksVagtr8%3D
-
Kang G, Cho EY, Shin JH, Chung JH, Kim JW, Oh YL (2012) Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule. Cancer Cytopathol 120(1):44–51. doi:10.1002/cncy.20179
-
(2012)
Cancer Cytopathol
, vol.120
, Issue.1
, pp. 44-51
-
-
Kang, G.1
Cho, E.Y.2
Shin, J.H.3
Chung, J.H.4
Kim, J.W.5
Oh, Y.L.6
-
55
-
-
84867839665
-
Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas
-
PID: 22514085, COI: 1:CAS:528:DC%2BC38XhsFamtrbE
-
Yim JH, Kim ES, Choi HJ, Jeon MJ, Han JM, Kim WG, Kim TY, Gong G, Kim SY, Kim WB, Shong YK (2012) Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas. J Surg Oncol 106(6):719–723. doi:10.1002/jso.23125
-
(2012)
J Surg Oncol
, vol.106
, Issue.6
, pp. 719-723
-
-
Yim, J.H.1
Kim, E.S.2
Choi, H.J.3
Jeon, M.J.4
Han, J.M.5
Kim, W.G.6
Kim, T.Y.7
Gong, G.8
Kim, S.Y.9
Kim, W.B.10
Shong, Y.K.11
-
56
-
-
48249084096
-
Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer
-
PID: 18470905, COI: 1:CAS:528:DC%2BD1cXpt1OrsLY%3D
-
Guan H, Ji M, Hou P, Liu Z, Wang C, Shan Z, Teng W, Xing M (2008) Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 113(2):247–255. doi:10.1002/cncr.23548
-
(2008)
Cancer
, vol.113
, Issue.2
, pp. 247-255
-
-
Guan, H.1
Ji, M.2
Hou, P.3
Liu, Z.4
Wang, C.5
Shan, Z.6
Teng, W.7
Xing, M.8
-
57
-
-
61449109161
-
High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes
-
PID: 19152441, COI: 1:CAS:528:DC%2BD1MXjs1Kjurs%3D
-
Oler G, Cerutti JM (2009) High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer 115(5):972–980. doi:10.1002/cncr.24118
-
(2009)
Cancer
, vol.115
, Issue.5
, pp. 972-980
-
-
Oler, G.1
Cerutti, J.M.2
-
58
-
-
77954201670
-
BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic
-
PID: 20009493, COI: 1:CAS:528:DC%2BC3cXptl2ltL0%3D
-
Sykorova V, Dvorakova S, Ryska A, Vcelak J, Vaclavikova E, Laco J, Kodetova D, Kodet R, Cibula A, Duskova J, Hlobilkova A, Astl J, Vesely D, Betka J, Hoch J, Smutny S, Cap J, Vlcek P, Novak Z, Bendlova B (2010) BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic. J Endocrinol Invest 33(5):318–324. doi:10.3275/6722
-
(2010)
J Endocrinol Invest
, vol.33
, Issue.5
, pp. 318-324
-
-
Sykorova, V.1
Dvorakova, S.2
Ryska, A.3
Vcelak, J.4
Vaclavikova, E.5
Laco, J.6
Kodetova, D.7
Kodet, R.8
Cibula, A.9
Duskova, J.10
Hlobilkova, A.11
Astl, J.12
Vesely, D.13
Betka, J.14
Hoch, J.15
Smutny, S.16
Cap, J.17
Vlcek, P.18
Novak, Z.19
Bendlova, B.20
more..
-
59
-
-
84876667088
-
TSH increases iodine uptake by thyroid cancer cells during BRAF silencing
-
PID: 22998776, COI: 1:CAS:528:DC%2BC38XhtlOns7vF
-
Kleiman DA, Buitrago D, Crowley MJ, Beninato T, Veach AJ, Zanzonico PB, Jin M, III TJF, Zarnegar R (2013) TSH increases iodine uptake by thyroid cancer cells during BRAF silencing. J Surg Res 182(1):85–93
-
(2013)
J Surg Res
, vol.182
, Issue.1
, pp. 85-93
-
-
Kleiman, D.A.1
Buitrago, D.2
Crowley, M.J.3
Beninato, T.4
Veach, A.J.5
Zanzonico, P.B.6
Jin, M.7
III, T.J.F.8
Zarnegar, R.9
-
60
-
-
67649970928
-
BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer
-
PID: 19414674, COI: 1:CAS:528:DC%2BD1MXoslyis7Y%3D
-
Xing MZ, Clark D, Guan HX, Ji MJ, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R (2009) BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27(18):2977–2982. doi:10.1200/Jco.2008.20.1426
-
(2009)
J Clin Oncol
, vol.27
, Issue.18
, pp. 2977-2982
-
-
Xing, M.Z.1
Clark, D.2
Guan, H.X.3
Ji, M.J.4
Dackiw, A.5
Carson, K.A.6
Kim, M.7
Tufaro, A.8
Ladenson, P.9
Zeiger, M.10
Tufano, R.11
-
61
-
-
41349122686
-
BRAF(V600E) mutation and the biology of papillary thyroid cancer
-
PID: 18310287, COI: 1:CAS:528:DC%2BD1cXkslKnurc%3D
-
Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R (2008) BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer 15(1):191–205. doi:10.1677/Erc-07-0212
-
(2008)
Endocr Relat Cancer
, vol.15
, Issue.1
, pp. 191-205
-
-
Frasca, F.1
Nucera, C.2
Pellegriti, G.3
Gangemi, P.4
Attard, M.5
Stella, M.6
Loda, M.7
Vella, V.8
Giordano, C.9
Trimarchi, F.10
Mazzon, E.11
Belfiore, A.12
Vigneri, R.13
-
62
-
-
84870726465
-
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study
-
PID: 23066120, COI: 1:CAS:528:DC%2BC38XhvVCgt7jE
-
Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F (2012) The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab 97(12):4390–4398. doi:10.1210/jc.2012-1775
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.12
, pp. 4390-4398
-
-
Elisei, R.1
Viola, D.2
Torregrossa, L.3
Giannini, R.4
Romei, C.5
Ugolini, C.6
Molinaro, E.7
Agate, L.8
Biagini, A.9
Lupi, C.10
Valerio, L.11
Materazzi, G.12
Miccoli, P.13
Piaggi, P.14
Pinchera, A.15
Vitti, P.16
Basolo, F.17
-
63
-
-
66749153133
-
BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma
-
PID: 19355825, COI: 1:CAS:528:DC%2BD1MXkt1CgsLk%3D
-
Gu LQ, Li FY, Zhao L, Liu Y, Zang XX, Wang TX, Chen HP, Ning G, Zhao YJ (2009) BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma. Thyroid 19(4):347–354. doi:10.1089/thy.2008.0246
-
(2009)
Thyroid
, vol.19
, Issue.4
, pp. 347-354
-
-
Gu, L.Q.1
Li, F.Y.2
Zhao, L.3
Liu, Y.4
Zang, X.X.5
Wang, T.X.6
Chen, H.P.7
Ning, G.8
Zhao, Y.J.9
-
64
-
-
84878394785
-
Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR
-
PID: 23690118, COI: 1:CAS:528:DC%2BC3sXpsFCnsLk%3D
-
Kang SH, Pyo JY, Yang SW, Hong SW (2013) Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR. Am J Clin Pathol 139(6):759–764. doi:10.1309/AJCPN3ULH6YWBHPH
-
(2013)
Am J Clin Pathol
, vol.139
, Issue.6
, pp. 759-764
-
-
Kang, S.H.1
Pyo, J.Y.2
Yang, S.W.3
Hong, S.W.4
-
65
-
-
84880427006
-
Clinical significance of BRAF mutation in thyroid papillary cancer
-
Fernandez IJ, Piccin O, Sciascia S, Cavicchi O, Repaci A, Vicennati V, Fiorentino M (2013) Clinical significance of BRAF mutation in thyroid papillary cancer. Otolaryngol-Head Neck Surg Off J Am AcaD Otolaryngol-Head Neck Surg 148 (6):919–925. doi:10.1177/0194599813481942
-
(2013)
Otolaryngol-Head Neck Surg Off J Am AcaD Otolaryngol-Head Neck Surg
, vol.148
, Issue.6
, pp. 919-925
-
-
Fernandez, I.J.1
Piccin, O.2
Sciascia, S.3
Cavicchi, O.4
Repaci, A.5
Vicennati, V.6
Fiorentino, M.7
-
66
-
-
84868626681
-
Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study
-
PID: 22930785, COI: 1:CAS:528:DC%2BC38Xhs12ku77O
-
Joo JY, Park JY, Yoon YH, Choi B, Kim JM, Jo YS, Shong M, Koo BS (2012) Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. J Clin Endocrinol Metab 97(11):3996–4003. doi:10.1210/jc.2012-2444
-
(2012)
J Clin Endocrinol Metab
, vol.97
, Issue.11
, pp. 3996-4003
-
-
Joo, J.Y.1
Park, J.Y.2
Yoon, Y.H.3
Choi, B.4
Kim, J.M.5
Jo, Y.S.6
Shong, M.7
Koo, B.S.8
-
67
-
-
35948938528
-
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
-
PID: 17785355, COI: 1:CAS:528:DC%2BD2sXhtlartb7E
-
Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P, Basolo F (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92(11):4085–4090. doi:10.1210/jc.2007-1179
-
(2007)
J Clin Endocrinol Metab
, vol.92
, Issue.11
, pp. 4085-4090
-
-
Lupi, C.1
Giannini, R.2
Ugolini, C.3
Proietti, A.4
Berti, P.5
Minuto, M.6
Materazzi, G.7
Elisei, R.8
Santoro, M.9
Miccoli, P.10
Basolo, F.11
-
68
-
-
40549135970
-
BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort
-
PID: 18383861
-
Goutas N, Vlachodimitropoulos D, Bouka M, Lazaris AC, Nasioulas G, Gazouli M (2008) BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res 28(1A):305–308
-
(2008)
Anticancer Res
, vol.28
, Issue.1A
, pp. 305-308
-
-
Goutas, N.1
Vlachodimitropoulos, D.2
Bouka, M.3
Lazaris, A.C.4
Nasioulas, G.5
Gazouli, M.6
-
70
-
-
66149139313
-
Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer
-
PID: 19190105, COI: 1:CAS:528:DC%2BD1MXlvVCqt70%3D
-
Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P, Zhang Y, Shan Z, Teng W, Xing M (2009) Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 94(5):1612–1617. doi:10.1210/jc.2008-2390
-
(2009)
J Clin Endocrinol Metab
, vol.94
, Issue.5
, pp. 1612-1617
-
-
Guan, H.1
Ji, M.2
Bao, R.3
Yu, H.4
Wang, Y.5
Hou, P.6
Zhang, Y.7
Shan, Z.8
Teng, W.9
Xing, M.10
-
71
-
-
33748747215
-
Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer
-
PID: 16772349, COI: 1:CAS:528:DC%2BD28Xpslaisrw%3D
-
Jo YS, Li S, Song JH, Kwon KH, Lee JC, Rha SY, Lee HJ, Sul JY, Kweon GR, Ro HK, Kim JM, Shong M (2006) Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer. J Clin Endocrinol Metab 91(9):3667–3670. doi:10.1210/jc.2005-2836
-
(2006)
J Clin Endocrinol Metab
, vol.91
, Issue.9
, pp. 3667-3670
-
-
Jo, Y.S.1
Li, S.2
Song, J.H.3
Kwon, K.H.4
Lee, J.C.5
Rha, S.Y.6
Lee, H.J.7
Sul, J.Y.8
Kweon, G.R.9
Ro, H.K.10
Kim, J.M.11
Shong, M.12
-
72
-
-
4143051232
-
BRAF mutations in an Italian cohort of thyroid cancers
-
COI: 1:CAS:528:DC%2BD2cXnslWlt70%3D
-
Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P (2004) BRAF mutations in an Italian cohort of thyroid cancers. Clin Endocrinol 61(2):239–243. doi:10.1111/j.1365-2265.2004.02089.x
-
(2004)
Clin Endocrinol
, vol.61
, Issue.2
, pp. 239-243
-
-
Fugazzola, L.1
Mannavola, D.2
Cirello, V.3
Vannucchi, G.4
Muzza, M.5
Vicentini, L.6
Beck-Peccoz, P.7
-
73
-
-
26644473629
-
No correlation between BRAF(V600E) mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan
-
Liu RT, Chen YJ, Chou FF, Li CL, Wu WL, Tsai PC, Huang CC, Cheng JT (2005) No correlation between BRAF(V600E) mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Clin Endocrinol 63(4):461–466. doi:10.1111/j.1365-2265.2005.02367.x
-
(2005)
Clin Endocrinol
, vol.63
, Issue.4
, pp. 461-466
-
-
Liu, R.T.1
Chen, Y.J.2
Chou, F.F.3
Li, C.L.4
Wu, W.L.5
Tsai, P.C.6
Huang, C.C.7
Cheng, J.T.8
-
74
-
-
33845415142
-
Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status
-
PID: 17044028, COI: 1:CAS:528:DC%2BD28XhtlSisL%2FE
-
Abrosimov A, Saenko V, Rogounovitch T, Namba H, Lushnikov E, Mitsutake N, Yamashita S (2007) Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status. Int J Cancer 120(1):196–200. doi:10.1002/ijc.22290
-
(2007)
Int J Cancer
, vol.120
, Issue.1
, pp. 196-200
-
-
Abrosimov, A.1
Saenko, V.2
Rogounovitch, T.3
Namba, H.4
Lushnikov, E.5
Mitsutake, N.6
Yamashita, S.7
-
75
-
-
84863385520
-
The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis
-
PID: 21882184, COI: 1:CAS:528:DC%2BC38XktFWmsbk%3D
-
Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH, Cho BY, do Park J (2012) The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer 118(7):1764–1773. doi:10.1002/cncr.26500
-
(2012)
Cancer
, vol.118
, Issue.7
, pp. 1764-1773
-
-
Kim, T.H.1
Park, Y.J.2
Lim, J.A.3
Ahn, H.Y.4
Lee, E.K.5
Lee, Y.J.6
Kim, K.W.7
Hahn, S.K.8
Youn, Y.K.9
Kim, K.H.10
Cho, B.Y.11
do Park, J.12
-
76
-
-
83555176093
-
Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma
-
PID: 22081104, COI: 1:STN:280:DC%2BC38%2FislCrtw%3D%3D
-
Eloy C, Santos J, Soares P, Sobrinho-Simoes M (2011) Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Arch 459(6):595–605. doi:10.1007/s00428-011-1161-3
-
(2011)
Virchows Arch
, vol.459
, Issue.6
, pp. 595-605
-
-
Eloy, C.1
Santos, J.2
Soares, P.3
Sobrinho-Simoes, M.4
-
77
-
-
40749104889
-
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma
-
COI: 1:CAS:528:DC%2BD1cXltVKku7Y%3D
-
Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, Garcia-Rostan G (2008) BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol 68(4):618–634. doi:10.1111/j.1365-2265.2007.03077.x
-
(2008)
Clin Endocrinol
, vol.68
, Issue.4
, pp. 618-634
-
-
Costa, A.M.1
Herrero, A.2
Fresno, M.F.3
Heymann, J.4
Alvarez, J.A.5
Cameselle-Teijeiro, J.6
Garcia-Rostan, G.7
|